STARmed Co., Ltd Expands Its Reach with the Launch of STARmed America in the USA
01 Aug 2023
LOS ANGELES, Aug. 1, 2023 /PRNewswire/ -- STARmed Co., Ltd, a leading medical device manufacturer specializing in thermal ablation technology, is thrilled to announce the launch of its subsidiary, STARmed America, in the USA. This strategic move aims to strengthen direct customer service and foster collaboration with the US market for cutting-edge thermal ablation technology. STARmed America will serve as a vital hub for innovation and collaboration.
STARmed Co., Ltd has emerged as a young and fast-growing company, dedicated to revolutionizing thermal ablation technology. The company specializes in radiofrequency ablation generators and electrodes, establishing a strong reputation both domestically and internationally. Working closely with Key Opinion Leaders (KOL) in the medical field has been a primary focus for STARmed, leading to the development of leading-edge radiofrequency (RF) technology for various clinical applications. STARmed America will further cultivate this culture of innovation, solidifying its commitment to pushing medical advancements through strategic partnerships.
"The mission at STARmed is to maintain the highest levels of innovation, knowledge, and technical expertise to provide solutions that enhance patient comfort and improve the quality of their lives," stated Henry Shin, CEO at STARmed Co., Ltd. "With the launch of STARmed America, we are poised to deliver on this mission by working closely with our USA customers and leveraging potential opportunities to advance thermal ablation technology even further."
With a remarkable presence in over 79 countries worldwide, STARmed has become a globally recognized and respected name in the industry. While originally focused on Liver RFA, STARmed has made significant strides in the development of RF technologies for Thyroid RFA. In less than 8 years, STARmed has emerged as the global leader in Thyroid RFA, with over 70% of clinical studies conducted using STARmed devices. The exceptional clinical results and low complication rates associated with the company's devices demonstrate the effectiveness and reliability of STARmed's technology.
As STARmed embarks on this exciting journey with the launch of STARmed America, the company remains committed to pushing the boundaries of thermal ablation technology and delivering unparalleled value to healthcare professionals and patients worldwide. STARmed is confident that its expanded presence in the USA will facilitate even greater advancements, furthering the mission to improve patient outcomes and transform lives.
For further information or media inquiries, please contact:
STARmed America
Email: info@starmed-america.com
Website: (COMING SOON)
About STARmed Co., Ltd:
STARmed Co., Ltd is a South Korean-based medical device manufacturer specializing in thermal ablation technology. With a focus on radiofrequency ablation generators and electrodes, the company has gained global recognition for its innovative solutions and commitment to improving patient outcomes. STARmed's mission is to maintain high levels of innovation, knowledge, and technical expertise to provide solutions for patients' comfort and improve the quality of their lives. For more information, visit .
View original content to download multimedia:
SOURCE STARmed Co., Ltd
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.